X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2199) 2199
Publication (166) 166
Book Review (11) 11
Conference Proceeding (2) 2
Data Set (2) 2
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1104) 1104
humans (913) 913
prognosis (870) 870
neutrophil-to-lymphocyte ratio (858) 858
lymphocytes (808) 808
inflammation (797) 797
female (784) 784
male (754) 754
middle aged (686) 686
neutrophils (636) 636
survival (584) 584
aged (574) 574
oncology (550) 550
to-lymphocyte ratio (526) 526
cancer (499) 499
adult (457) 457
neutrophil to lymphocyte ratio (456) 456
retrospective studies (453) 453
analysis (389) 389
lymphocyte count (328) 328
mortality (323) 323
surgery (294) 294
neutrophil (282) 282
care and treatment (276) 276
chemotherapy (276) 276
c-reactive protein (272) 272
platelet-to-lymphocyte ratio (264) 264
medical prognosis (259) 259
leukocyte count (251) 251
aged, 80 and over (240) 240
medical research (229) 229
research (220) 220
medicine, experimental (218) 218
metastasis (217) 217
patients (210) 210
risk factors (210) 210
association (206) 206
biomarkers (206) 206
multivariate analysis (202) 202
neutrophil/lymphocyte ratio (200) 200
predictive value of tests (198) 198
health aspects (182) 182
blood platelets (176) 176
disease-free survival (174) 174
diagnosis (172) 172
fungi (171) 171
lymphocytes - pathology (171) 171
platelet to lymphocyte ratio (170) 170
medicine, general & internal (167) 167
outcomes (167) 167
platelet count (167) 167
neutrophils - pathology (166) 166
disease (158) 158
blood (155) 155
medicine & public health (155) 155
mean platelet volume (152) 152
roc curve (149) 149
studies (149) 149
tumors (148) 148
recurrence (145) 145
treatment outcome (144) 144
patient outcomes (139) 139
biomarkers - blood (138) 138
carcinoma (137) 137
development and progression (137) 137
risk (134) 134
proportional hazards models (133) 133
platelet (131) 131
meta-analysis (125) 125
research article (124) 124
kaplan-meier estimate (123) 123
young adult (123) 123
medicine (122) 122
neoplasm staging (120) 120
survival analysis (120) 120
original (117) 117
cancer therapies (109) 109
hematology (108) 108
predictor (107) 107
resection (107) 107
medicine, research & experimental (106) 106
neoplasms. tumors. oncology. including cancer and carcinogens (104) 104
colorectal-cancer (103) 103
pretreatment neutrophil (103) 103
biomarker (102) 102
hepatocellular carcinoma (102) 102
colorectal cancer (98) 98
marker (98) 98
cell biology (97) 97
original article (97) 97
survival rate (96) 96
neutrophils - cytology (95) 95
overall survival (95) 95
blood cell count (94) 94
lung cancer (94) 94
original research (91) 91
atherosclerosis (90) 90
urology & nephrology (90) 90
follow-up studies (88) 88
lymphocyte ratio (85) 85
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2137) 2137
Turkish (21) 21
Korean (17) 17
German (8) 8
Spanish (7) 7
Portuguese (6) 6
Chinese (5) 5
Japanese (5) 5
French (1) 1
Indonesian (1) 1
Persian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Surgical Oncology, ISSN 0022-4790, 05/2016, Volume 113, Issue 6, pp. 621 - 627
Journal Article
Diseases of the Esophagus, ISSN 1120-8694, 07/2016, Volume 29, Issue 5, pp. 403 - 411
Journal Article
Otology & Neurotology, ISSN 1531-7129, 06/2019, Volume 40, Issue 5, pp. 681 - 687
OBJECTIVE:Bellʼs palsy (BP) is the most common cause of unilateral peripheral facial paralysis, and inflammation has been proposed as the main pathological... 
SYSTEM | Platelet-to-lymphocyte ratio | HERPES-SIMPLEX-VIRUS | MULTICENTER | ACYCLOVIR | Neutrophil-to-lymphocyte ratio | OTORHINOLARYNGOLOGY | PREDNISOLONE | CLINICAL NEUROLOGY | Bell's palsy | Meta-analysis | Blood platelets | Lymphocytes | Analysis | Neutrophils | Research | Biological markers
Journal Article
Journal Article
Journal Article
Journal Article
LUNG CANCER, ISSN 0169-5002, 09/2017, Volume 111, pp. 176 - 181
Objectives: Immunotherapy with the programmed death receptor-1 (PD-1) antibody nivolumab has changed the field of metastatic non-small cell lung cancer (NSCLC)... 
SURVIVAL | Neutrophil-to-Lymphocyte ratio | METAANALYSIS | SOLID TUMORS | Non small cell lung cancer | DOCETAXEL | TRI